NCT01355367View on ClinicalTrials.gov

High Dose BAYA1040 CR: a Long Term Extension Study

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

April 30, 2012

Conditions
Hypertension
Interventions
DRUG

Nifedipine (Adalat, BAYA1040)

BAYA1040 CR 40mg BID

Trial Locations (22)

036-8082

Hirosaki

273-0100

Kamagaya

070-0061

Asahikawa

078-8214

Asahikawa

003-0026

Sapporo

003-0825

Sapporo

004-0004

Sapporo

007-0841

Sapporo

062-0053

Sapporo

063-0841

Sapporo

064-0803

Sapporo

064-0807

Sapporo

210-0852

Kawasaki

574-0074

Daitō

596-8522

Kishiwada

581-0011

Yao

359-1141

Tokorozawa

421-0193

Shizuoka

192-0046

Hachiōji

152-0031

Meguro City

105-7390

Minato

108-0075

Minato

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01355367 - High Dose BAYA1040 CR: a Long Term Extension Study | Biotech Hunter | Biotech Hunter